PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000975328.40621.c2 |
| _version_ | 1797281608230764544 |
|---|---|
| author | Yuehua Ding Minqiu Lu Bin Chu Lei Shi Shan Gao Qiuqing Xiang Lijuan Fang Yutong Wang XI Liu Xin Zhao Mengzhen Wang Yuan Chen Sun Kai LI Bao |
| author_facet | Yuehua Ding Minqiu Lu Bin Chu Lei Shi Shan Gao Qiuqing Xiang Lijuan Fang Yutong Wang XI Liu Xin Zhao Mengzhen Wang Yuan Chen Sun Kai LI Bao |
| author_sort | Yuehua Ding |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:58:53Z |
| format | Article |
| id | doaj.art-4bb23dba36464bee9341af3c97a2fdf4 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:58:53Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-4bb23dba36464bee9341af3c97a2fdf42024-03-03T03:25:46ZengWileyHemaSphere2572-92412023-08-017e40621c210.1097/01.HS9.0000975328.40621.c2202308003-02006PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIAYuehua Ding0Minqiu Lu1Bin Chu2Lei Shi3Shan Gao4Qiuqing Xiang5Lijuan Fang6Yutong Wang7XI Liu8Xin Zhao9Mengzhen Wang10Yuan Chen11Sun Kai12LI Bao131 Beijing Jishuitan Hospital, Department of Hematology, China1 Beijing Jishuitan Hospital, Department of Hematology, China1 Beijing Jishuitan Hospital, Department of Hematology, China1 Beijing Jishuitan Hospital, Department of Hematology, China1 Beijing Jishuitan Hospital, Department of Hematology, China2 Beijing Jishuitan Hospital, Department of Hematology, China3 Beijing Jishuitan Hospital, Department of Hematology, China3 Beijing Jishuitan Hospital, Department of Hematology, China3 Beijing Jishuitan Hospital, Department of Hematology, China3 Beijing Jishuitan Hospital, Department of Hematology, China3 Beijing Jishuitan Hospital, Department of Hematology, China4 Beijing Jishuitan Hospital, Department of Hematology, China1 Beijing Jishuitan Hospital, Department of Hematology, China2 Beijing Jishuitan Hospital, Department of Hematology, Chinahttp://journals.lww.com/10.1097/01.HS9.0000975328.40621.c2 |
| spellingShingle | Yuehua Ding Minqiu Lu Bin Chu Lei Shi Shan Gao Qiuqing Xiang Lijuan Fang Yutong Wang XI Liu Xin Zhao Mengzhen Wang Yuan Chen Sun Kai LI Bao PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA HemaSphere |
| title | PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA |
| title_full | PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA |
| title_fullStr | PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA |
| title_full_unstemmed | PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA |
| title_short | PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA |
| title_sort | pb2142 serum osteocalcin as a predictor for the risk of denosumab and bisphosphonate induced hypocalcemia in myeloma patients with hypercalcemia |
| url | http://journals.lww.com/10.1097/01.HS9.0000975328.40621.c2 |
| work_keys_str_mv | AT yuehuading pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT minqiulu pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT binchu pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT leishi pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT shangao pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT qiuqingxiang pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT lijuanfang pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT yutongwang pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT xiliu pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT xinzhao pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT mengzhenwang pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT yuanchen pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT sunkai pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia AT libao pb2142serumosteocalcinasapredictorfortheriskofdenosumabandbisphosphonateinducedhypocalcemiainmyelomapatientswithhypercalcemia |